A revolution in DNA-sequencing technology in the past few years has allowed relatively easy identification of the underlying causes of many genetic diseases. However, preventing transmission of diseasecausing defects remains a formidable challenge. Our cells contain two genomes -one in the nucleus and another much smaller, semiautonomous one in organelles called mitochondria, which are essential for the production of energy. Diseases caused by mutations in mitochondrial DNA (mtDNA) affect about 1 in 5,000 people 1 , have an extraordinarily broad spectrum of symptoms and are currently untreatable. Kang et al. 2 show on page 270 that it is possible to prevent harmful mutations in human mtDNA from being transmitted to offspring, using a mitochondrial replacement technique.
We inherit all of our mitochondria, and so all of our mtDNA, from our mothers. Female eggs carry a few hundred thousand copies of mtDNA, and most cells in an adult contain hundreds to thousands of these copies. In individuals with mtDNA disease there is usually a mixture of normal and mutated mtDNAs, and the severity of disease generally correlates with the proportion of mtDNA copies that carry the disease-causing mutation.
This proportion can vary widely between eggs from the same woman. One way to avoid the transmission of mutations is to combine in vitro fertilization (IVF) with genetic diagnosis to identify and implant only embryos harbouring normal mtDNAs. Although this approach has been successful 3 , it is not always possible to recover suitable embryos.
Another strategy might be to swap the mitochondria containing mutated mtDNA for healthy ones (Fig. 1) . This is the idea behind mitochondrial replacement techniques (MRTs). In one MRT, known as meioticspindle transfer, nuclear DNA from the egg of a 'carrier' mother harbouring mutated mtDNA would be transferred to a donor egg that lacks a nucleus and contains only normal copies of mtDNA. This egg would then be fertilized in vitro and implanted. A variation on the theme is pronuclear transfer, in which the nuclei from the sperm and egg would be transferred to a nucleus-free donor egg immediately after fertilization, before the two have fused.
In both cases, the reconstituted embryo would carry the same genes as its biological parents, except for the few on mtDNA that come from an unrelated donor. The group that conducted the current study has previously performed proof-of-principle One such therapy would be transfer of pronuclei -sperm and egg nuclei post-fertilization, before the two fuse -from an egg that harbours some mutated mtDNAs into a donor cell that has healthy mtDNA, from which the nucleus has been removed. In another technique, known as meiotic-spindle transfer, nuclear DNA from an egg harbouring some mutant mtDNAs would be transferred into a nucleus-free egg, which would subsequently be fertilized. Kang et al. 2 provide evidence that meiotic-spindle transfer can produce healthy embryos at the blastocyst stage of development that are free of mutant mtDNA.
that small increases in greenhouse gases due to the expansion of agriculture that started 8,000 years ago 10 have, in fact, delayed the next ice age 11 . More over, if greenhouse-gas emissions continue to grow, the next ice age might be postponed for at least half a million years 12 . Understanding orbital forcing is therefore relevant to contemporary debates about the Anthropocene -a proposed geological unit that is defined by human activity. If we have merely delayed the next ice age, we will still be in the Quaternary period, and the Anthropocene can be defined as an epoch, a subdivision of time below a period. But . This probably would not be much of a worry for therapeutics, because most cells would lose the rare mtDNAs carrying the mutation.
But Kang and colleagues' study shows that, in some cases, the carrier mtDNA could have a replicative advantage over mtDNA from the donor, probably owing to sequence variation in the region of mtDNA that regulates the replication rate of the mitochondrial genome. This phenomenon could perpetuate a systematic return to a majority of carrier mtDNA. As the authors suggest, it should be possible to select donors on the basis of relative efficiencies of mtDNA replication when studying the process in model systems. But the problem cannot be directly studied in human embryos, because mtDNA replication is stalled until after the blastocyst stage. It would, however, be useful to investigate the phenomenon in other mammals, where it is possible to study replication of mtDNA throughout early embryonic development.
Aside tests to show that meiotic-spindle transfer can produce healthy macaque offspring 4 and human embryos that develop normally up to the blastocyst stage at five days of development 5 . Earlier this year, another group had a similar success with pronuclear transfer 6 . However, these studies used carrier eggs that contained normal mtDNA only.
In the current study, Kang et al. turned to eggs from women carrying single-nucleotide mtDNA mutations. The authors successfully used meiotic-spindle transfer to produce embryos that developed to the blastocyst stage and that carried a virtually undetectable proportion of mutant mtDNAs. So, it seems that the precise timing of nuclear transfer (before or after fertilization) is unimportant. However, because pronuclear transfer has not been attempted using eggs from women carrying mutant mtDNA, a direct comparison would be required to confirm this speculation.
Concerns have been raised about possible nuclear-mitochondrial incompatibilities resulting from MRT -the idea that certain combinations of nuclear and mitochondrial genomes could have adverse effects on cell fitness. However, evidence to support such concerns is based on studies of inbred mice 7, 8 , which have no genetic variation in their nuclear genomes. Human populations, by contrast, are highly heterogeneous, and so paternal genes find themselves in a potentially novel mtDNA environment with each generation. Thus, it seems unlikely that any kind of tight coupling would have evolved between nuclear and mitochondrial DNA in humans. Indeed, Kang and colleagues show that embryo development is independent of the genetic distance between the mtDNA of the carrier and that of the donor, corroborating observations 5 in a macaque MRT experiment that used donors and carriers with highly divergent mtDNAs.
Another concern is the fate of the 2% or so of mtDNA copies that hitch-hike with the nucleus from the carrier egg into the reconstituted embryo. To investigate the potential consequences of such hitch-hiking, Kang et al. analysed embryonic stem cells that they isolated from the reconstructed embryos and grew in culture. Their analyses showed that, in rare instances, donor mtDNAs can be outcompeted by even small proportions of carrier mtDNA after a large number of cell divisions -in line with the results of two previous studies 6, 9 . Two possible mechanisms could be in play here: genetic drift (random changes to genetic make-up that occur over generations) and replicative advantage. If the changes seen in mtDNA proportions are due entirely to genetic drift, the probability that a rare mutation in a mixed mtDNA population will become predominant is directly proportional to its initial frequency -as has been demonstrated in vivo for cells in crypt structures in the colon, which are continuously regenerated from a stem-cell
STEM CELLS

Aspiring to naivety
Human stem cells that can give rise to every cell type in the body are major players in biomedical research. A molecular analysis of human embryos might help to make these cultured cells more authentic imitations of their in vivo counterparts.
I D O S AG I & N I S S I M B E N V E N I ST Y
H uman embryonic stem cells have revolutionized biomedical research, thanks to the fact that they are pluripotent: able to differentiate into every cell lineage of the body. These cells are grown in culture, after being isolated at the blastocyst stage of early development from an embryo produced by in vitro fertilization. But under conventional culture conditions, embryonic stem cells are not considered to be naive pluripotent stem cells (PSCs) -those identical to cells of the blastocyst from which they are derived. Instead, they are regarded as primed PSCs, resembling more-mature cells that are poised to differentiate 1 . Writing in Cell Stem Cell, Theunissen et al. 2 describe a set of criteria that define naive human PSCs, and so take an important step towards generating truly naive cells in culture. Such an ability could provide opportunities to study early developmental processes, which in turn could make it possible to optimize cell-differentiation protocols for disease modelling and therapy.
In the past few years, several groups of researchers have defined culture conditions that seem to sustain human PSCs in a blastocyst-like naive state, either by conversion from the primed state or by direct isolation from embryos [3] [4] [5] [6] (Fig. 1) . However, it has remained unclear exactly how similar these 'naive' cells are to in vivo blastocyst cells. The different cocktails of growth factors and small molecules used by each research group produced human cells that had some properties of naive mouse pluripotency, and that varied in their resemblance to the human blastocyst in terms of gene expression 7 . However, embryonic development is substantially different in humans and mice with regard to timing, morphology and at the molecular level. As such, comparisons with mouse pluripotency might be a misleading way to gauge the state of human cells. To overcome this obstacle, Theunissen et al. turned to human embryos.
